Difference between revisions of "More about us"

From Opengenome.net
 
(54 intermediate revisions by 3 users not shown)
Line 1: Line 1:
 
<p>&nbsp;</p>
 
<p>&nbsp;</p>
<p style="text-align: center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<span style="background-color: #ffffff">&nbsp;&nbsp;</span><span style="color: #0000ff"><span style="background-color: #ffffff"><span style="font-size: xx-large"><b><span style="font-family: Times New Roman">K</span></b></span></span></span><span style="color: #000000"><span style="font-size: xx-large"><b><span style="font-family: Times New Roman">orean</span></b></span></span><span style="font-size: xx-large"><span style="color: #808080"><b><span style="font-family: Times New Roman"> <span style="color: #800000">P</span><span style="color: #333333"><span style="background-color: #ffffff">ersonal</span></span><span style="background-color: #ffffff"> </span><span style="color: #990000"><span style="background-color: #ffffff">G</span></span><span style="color: #666666">enome</span> <span style="color: #cc0000">P</span></span></b></span></span><span style="color: #999999"><span style="font-size: xx-large"><b><span style="font-family: Times New Roman">roject</span></b></span></span><span style="color: #c0c0c0"><b><span style="font-size: large"><span style="font-family: Comic Sans MS">&nbsp;</span></span></b></span><span style="color: #808080"><span style="font-size: large"><span style="font-family: Comic Sans MS">&nbsp;&nbsp;<img style="width: 126px; height: 125px" alt="" width="130" height="130" src="/userfiles/1.png" /></span></span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
+
<p style="text-align: center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<span style="background-color: #ffffff">&nbsp;&nbsp;</span><span style="color: #0000ff"><span style="background-color: #ffffff"><span style="font-size: xx-large"><b><span style="font-family: Times New Roman">K</span></b></span></span></span><span style="color: #000000"><span style="font-size: xx-large"><b><span style="font-family: Times New Roman">orean</span></b></span></span><span style="font-size: xx-large"><span style="color: #808080"><b><span style="font-family: Times New Roman"> <span style="color: #cc0000">P</span><span style="color: #333333"><span style="background-color: #ffffff">ersonal</span></span><span style="background-color: #ffffff"> </span><span style="color: #cc0000"><span style="background-color: #ffffff">G</span></span><span style="color: #666666">enome</span> <span style="color: #cc0000">P</span></span></b></span></span><span style="color: #999999"><span style="font-size: xx-large"><b><span style="font-family: Times New Roman">roject</span></b></span></span><span style="color: #c0c0c0"><b><span style="font-size: large"><span style="font-family: Comic Sans MS">&nbsp;</span></span></b></span><span style="color: #808080"><span style="font-size: large"><span style="font-family: Comic Sans MS">&nbsp;&nbsp;<img style="height: 125px; width: 126px" alt="" width="130" height="130" src="/userfiles/1.png" /></span></span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
 
<h2>Introduction</h2>
 
<h2>Introduction</h2>
<div>&nbsp;Korean Personal Genome Project (KPGP) is a participative research project established by <a href="http://genomefoundation.org/index.php/Main_Page">Genome Research Foundation</a> (GRF). The international <a href="http://www.personalgenomes.org/">Personal Genome Project</a> (PGP), led by U.S. none-profit research group, is founded in 2006 and seeking a diverse range of volunteers with the purpose of improving human health. In concordance with the international PGP, KPGP has started to improve Korean people's health and medical welfare.</div>
+
<div><span style="font-size: small">Korean Personal Genome Project (KPGP) is a research project by </span><a href="http://genomefoundation.org/index.php/Main_Page"><span style="font-size: small">Genome Research Foundation</span></a><span style="font-size: small"> (GRF). It is a part of PGP (The international </span><a href="http://www.personalgenomes.org/"><span style="font-size: small">Personal Genome Project</span></a><span style="font-size: small"> (PGP).</span></div>
<h2><br />
 
Vision</h2>
 
<div>KPGP is aiming to advance science research, in order to promote human health and welfare with the keep of geopme technology.</div>
 
 
<h2>Mission</h2>
 
<h2>Mission</h2>
<p>- to build a standard Koarea genetic information database</p>
+
<ul>
<p>- to activate the participative genome research</p>
+
    <li>&nbsp;to function as Korean center for PGP (Harvard Medical School, George Church lab)</li>
<p>- to develop genome sequencing and analysis technologies in the age of personal genetic information services</p>
+
    <li>&nbsp;to build a standard Korean genetic information database</li>
<p>- to establish an open community if sharing ethical, social, and legal issued in regard togenetic information</p>
+
    <li>&nbsp;to activate the participative genome research</li>
 +
    <li>&nbsp;to develop genome sequencing and analysis technologies in the age of personal genetic information services</li>
 +
    <li>&nbsp;to establish an open community if sharing ethical, social, and legal issued in regard to genetic information</li>
 +
</ul>
 
<h2>Research</h2>
 
<h2>Research</h2>
<p>Korean reference genome project</p>
+
<ul>
<p>Rare diseases reference genome project</p>
+
    <li>Korean reference genome project</li>
<p>HLA alleles reference standard data production project</p>
+
    <li>Rare diseases reference genome project</li>
 +
    <li>HLA alleles reference standard data production project</li>
 +
</ul>
 
<h2>Participation&nbsp;</h2>
 
<h2>Participation&nbsp;</h2>
<p>Genetic Information Participation It is public participation, and human human genetics education, screening and participant`s willingness determined an individual's participation.&nbsp; Research Participation People who have research experiences in the field of human genetics, or who are willing to contribute to KPGP can participate through screening.&nbsp; Company Participation Institutes and companies could participate. Sponsorship can greatly help KPGP`s activation. <br />
+
<p><b>Genetic Information Participation</b></p>
 +
<p>It is a public participation. The human genetics education, screening and participant`s willingness determine an individual's participation.&nbsp;</p>
 +
<p><b>Research Participation </b></p>
 +
<p>People who have research experiences in the field of human genetics, or who are willing to contribute to KPGP can participate through screening.&nbsp;</p>
 +
<p><b>Company Participation </b></p>
 +
<p>Institutes and companies could participate. Sponsorship can greatly help KPGP`s activation.</p>
 +
<p><br />
 
Human genome researches have developed rapidly since the human genome project was completed in 2003. Recently large-scale production of human genome data is available with the advent of Next Generation Sequencing (NGS).</p>
 
Human genome researches have developed rapidly since the human genome project was completed in 2003. Recently large-scale production of human genome data is available with the advent of Next Generation Sequencing (NGS).</p>
<p>Genome Research Foundation (GRF), as a non-profit foundation, determined to open Korean genome data and the current available data of human genome sequence and analysis for free to allow researchers to study. Under the circumstances, OPEN KPGP started on 2011.</p>
+
<p>Genome Research Foundation (GRF), as a non-<span style="font-size: larger">profit foundation, determines </span>to open Korean genome data and the current available data of human genome sequence and analysis for free to allow researchers to study. Under the circumstances, OPEN KPGP started on 2011.</p>
 
<p>&nbsp;</p>
 
<p>&nbsp;</p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: 18pt; font-family: &quot;맑은 고딕&quot;; font-weight: bold; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 1">Genetic Data Usage Agreement for Research</span><span style="font-size: 18pt; font-family: &quot;맑은 고딕&quot;; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 1"> </span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: 18pt; font-family: &quot;맑은 고딕&quot;; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 1">&nbsp;</span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; font-weight: bold; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">1) Data Type</span></span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">Every derived genetic information should be approved by relevant facility board.</span></span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">1. Genetic information data- Individual's sequenced DNA and analyzed data.</span></span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">2. Clinical information data- Clinical information does not include family tree, Phenotype and family medical history.</span></span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; font-weight: bold; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">2) The Commission Process</span></span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">1. Bioethics committee of Genome Research Foundation will make a decision through policy reviews and case consultation.</span></span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">2. The Standards Commission</span></span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">This commission should be controlled by Korea National Institute for Bioethics Policy.</span></span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">Research, associate with potential social risks, </span><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">eugenical</span><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13"> problem and discrimination on the basis of genetic information when it comes to any aspects of physical looking, should be forbidden. </span></span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">3. The Commission Process</span></span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">Research project and IRB document, approved in each countries, will be required. If there is no provision for IRB approval, User must agree with additional consent documents that embodies the purpose of the data.</span></span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">4. Evaluation (It will take at least one week)</span></span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; font-weight: bold; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">3) Policy </span><span style="font-family: '맑은 고딕'; font-weight: bold; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">Agrement</span><span style="font-family: '맑은 고딕'; font-weight: bold; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13"> </span></span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">Informed consent shall be documented by the use of a written consent form approved by the IRB, and signed by the subject or the subject's legally </span><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">authourized</span><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13"> representative.</span></span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">And if necessary, the committee may request, require or otherwise obtain detailed investigation.</span></span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">Data Release</span></span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">Any additional costs to the subject that may result from participation in the research.</span></span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; font-weight: bold; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">4) Data Source </span><span style="font-family: '맑은 고딕'; font-weight: bold; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">Agrement</span><span style="font-family: '맑은 고딕'; font-weight: bold; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13"> </span></span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">The Genome Research Foundation should review and approve specifying the conditions under which data may be accepted, and ensuring adequate provisions to protect the privacy of subjects and maintain the confidentiality of data.</span></span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">To cite the data source in any publications or research based upon these data, and to provide a copy of any publications, the following citation should be included in any research reports, papers, or publications based on these data:</span></span></p>
 +
<p style="margin-bottom: 0pt; unicode-bidi: embed; direction: ltr; text-align: left; margin-left: 0in; margin-top: 0pt; language: ko; mso-line-break-override: none; punctuation-wrap: hanging"><span style="font-size: larger"><span style="font-family: '맑은 고딕'; color: black; language: en-US; mso-ascii-font-family: '맑은 고딕'; mso-fareast-font-family: '맑은 고딕'; mso-bidi-font-family: +mn-cs; mso-font-kerning: 12.0pt; mso-color-index: 13">Produced and distributed data should have references in Acknowledgement, Methods, Abstract. </span></span></p>
 
<h2>How to download</h2>
 
<h2>How to download</h2>
<p>After accessing to the OPEN KPGP website, select the desired data from DATA DOWNLOAD to download it through the Web and FTP. <br />
+
<p><span style="font-size: small">After accessing to the OPEN KPGP website, select the desired data from DATA DOWNLOAD to download it through the Web and FTP. <br />
Please understand that the downloading may be very slow due to Network load. (The speed of downloading 20 people&rsquo;s data through KT cloud is stable, please use it as an alternativ.)</p>
+
Please understand that the downloading may be very slow due to Network load. (The speed of downloading 20 people&rsquo;s data through KT cloud is stable, please use it as an alternative.)</span></p>
 
<p>&nbsp;</p>
 
<p>&nbsp;</p>
<h2>Hard disk Request</h2>
+
<h2>Hard disk request</h2>
<p>You can get data hard disks by requesting it to the administrator. However, the hard disk and processing costs will occur. <br />
+
<p><span style="font-size: small">You can get data hard disks by requesting it to the administrator. However, the hard disk and processing costs will occur. <br />
Cost <br />
+
Cost:</span></p>
- Hard disk<br />
+
<ul>
- Operating costs (labor and server equipment operating costs).<br />
+
    <li><span style="font-size: small">Hard disks</span></li>
- Shipping : door to door delivery(domestic only) / international shipping : please contact. (<a href="mailto:info@kpgp.kr">info@kpgp.kr</a>)</p>
+
    <li><span style="font-size: small">Operating costs (labor and server equipment operating costs). </span></li>
<table border="1" cellspacing="1" cellpadding="1" width="200">
+
    <li><span style="font-size: small">Shipping : door to door delivery(domestic only) / international shipping : please contact. (</span><a href="mailto:info@kpgp.kr"><span style="font-size: small">info@kpgp.kr</span></a><span style="font-size: small">)&nbsp;</span><span style="font-size: small">&nbsp; </span></li>
 +
</ul>
 +
<p><span style="font-size: small"><span lang="EN-US"><font size="2" face="맑은 고딕">(The data charges are variable based on the quantity and price of the hard disk, one hard disk can contain different numbers of samples.) </font></span></span></p>
 +
<p><span style="font-size: small">1) Raw sequencing data</span></p>
 +
<table style="height: 95px; width: 242px" cellspacing="1" cellpadding="1" width="242" border="1">
 
     <tbody>
 
     <tbody>
 
         <tr>
 
         <tr>
Line 37: Line 72:
 
         </tr>
 
         </tr>
 
         <tr>
 
         <tr>
             <td>10</td>
+
             <td>~10</td>
 
             <td>115,000 (KRW)&nbsp;</td>
 
             <td>115,000 (KRW)&nbsp;</td>
 
         </tr>
 
         </tr>
 
         <tr>
 
         <tr>
             <td>20</td>
+
             <td>~20</td>
 
             <td>170,000 (KRW)</td>
 
             <td>170,000 (KRW)</td>
 
         </tr>
 
         </tr>
 
         <tr>
 
         <tr>
             <td>30</td>
+
             <td>~30</td>
 
             <td>260,000 (KRW)</td>
 
             <td>260,000 (KRW)</td>
 
         </tr>
 
         </tr>
 
         <tr>
 
         <tr>
             <td>40</td>
+
             <td>~40</td>
 
             <td>340,000 (KRW)</td>
 
             <td>340,000 (KRW)</td>
 
         </tr>
 
         </tr>
 
     </tbody>
 
     </tbody>
 
</table>
 
</table>
<table border="1" cellspacing="1" cellpadding="1" width="200">
+
<p>&nbsp;2) Data included : raw sequencing data, aligned data, genome variation, nonsynonymous SNVs</p>
 +
<p>
 +
<table style="height: 95px; width: 242px" cellspacing="1" cellpadding="1" width="242" border="1">
 
     <tbody>
 
     <tbody>
 
         <tr>
 
         <tr>
Line 61: Line 98:
 
         </tr>
 
         </tr>
 
         <tr>
 
         <tr>
             <td>10</td>
+
             <td>~10</td>
 
             <td>310,000 (KRW)&nbsp;</td>
 
             <td>310,000 (KRW)&nbsp;</td>
 
         </tr>
 
         </tr>
 
         <tr>
 
         <tr>
             <td>20</td>
+
             <td>~20</td>
 
             <td>530,000 (KRW)&nbsp;</td>
 
             <td>530,000 (KRW)&nbsp;</td>
 
         </tr>
 
         </tr>
 
         <tr>
 
         <tr>
             <td>30</td>
+
             <td>~30</td>
 
             <td>750,000 (KRW)</td>
 
             <td>750,000 (KRW)</td>
 
         </tr>
 
         </tr>
 
         <tr>
 
         <tr>
             <td>40</td>
+
             <td>~40</td>
 
             <td>880,000 (KRW)</td>
 
             <td>880,000 (KRW)</td>
 
         </tr>
 
         </tr>
 
     </tbody>
 
     </tbody>
 
</table>
 
</table>
 +
</p>
 +
<p>&nbsp;Date for pricing: 2011.09</p>
 +
<h2><span id="1..C2.A0Sample.28gDNA.29_Preparation" class="mw-headline">Method of Sample (gDNA) Preparation for Sending out</span>&nbsp;</h2>
 +
<p><span style="font-size: small"><b><span id="1..C2.A0Sample.28gDNA.29_Preparation" class="mw-headline">1.&nbsp;Sample(gDNA) Preparation</span></b></span></p>
 +
<p><span style="font-size: small">1)&nbsp;&nbsp;DNA should be dissolved in TE buffer (Tris 10mM pH 8,0, 0.1 mM EDTA) or 10 mM Tris pH 8.0.</span></p>
 +
<p><span style="font-size: small">2)&nbsp;&nbsp;Do Not Dissolve in Water</span></p>
 
<p>&nbsp;</p>
 
<p>&nbsp;</p>
 +
<p><b><span style="font-size: small"><span id="2..C2.A0Sample.28gDNA.29_Requirement" class="mw-headline">2.&nbsp;Sample(gDNA) Requirement</span></span></b></p>
 +
<p><span style="font-size: small">1)&nbsp;&nbsp;&nbsp;Amount and concentration spec.&nbsp;: over 20 ug of gDNA with &gt;50 ng/ul</span></p>
 +
<p><span style="font-size: small">&nbsp;This amount is required for</span></p>
 +
<p><span style="font-size: small">a.&nbsp;&nbsp;Whole genome sequencing (30X)</span></p>
 +
<p><span style="font-size: small">b.&nbsp;&nbsp;Whole exome sequencing (50X)</span></p>
 +
<p><span style="font-size: small">c.&nbsp;&nbsp;Genotyping</span></p>
 +
<p><span style="font-size: small">2)&nbsp;&nbsp;Sample(gDNA) should be&nbsp;: OD260/280=1.8~2.0; free of protein, RNA, or other visible contamination</span></p>
 +
<p><span style="font-size: small">&nbsp;</span></p>
 +
<p><b><span style="font-size: small"><span id="3..C2.A0Sample.28gDNA.29_Packing_Information.C2.A0" class="mw-headline">3.&nbsp;Sample(gDNA) Packing Information&nbsp;</span></span></b></p>
 +
<p><span style="font-size: small">This way is only available when DNA is dissolved in TE or Tris buffer.</span></p>
 +
<p><span style="font-size: small">1)&nbsp;&nbsp;If not, please pack DNA with icepack in icebox and use Fedex or DHL service</span></p>
 +
<p><span style="font-size: small">2)&nbsp;&nbsp;Mark sample information on tube (concentration, sample name&hellip;what you want)</span></p>
 +
<p><span style="font-size: small">3)&nbsp;&nbsp;Seal the cap of tube with parafilm well</span></p>
 +
<p><span style="font-size: small">4)&nbsp;&nbsp;Wrap the tube with paper towel or equivalent</span></p>
 +
<p><span style="font-size: small">5)&nbsp;&nbsp;Put into the 50 ml Falcon tube and close the cap</span></p>
 +
<p><span style="font-size: small">6)&nbsp;&nbsp;Send the sample with air cushion envelop by FEDEX or DHL or equivalent</span></p>
 
<p>&nbsp;</p>
 
<p>&nbsp;</p>
 +
<p><b><span style="font-size: small"><span id="4..C2.A0Requirement_of_Sample.28gDNA.29_Information" class="mw-headline">4.&nbsp;Requirement of Sample(gDNA) Information</span></span></b></p>
 +
<p>1)&nbsp; Sample type: DNA</p>
 +
<p>2)&nbsp; Condition: DNA in TE buffer or EB buffer or equivalent. Not in water</p>
 +
<p>3)&nbsp; Gel image of DNA electrophoresis</p>
 +
<p>4)&nbsp; Species</p>
 +
<p>5)&nbsp; No. of Tubes</p>
 +
<p>6)&nbsp; Concentration (ng/&mu;l)</p>
 +
<p>7)&nbsp; Volume (&mu;l)</p>
 +
<p>8) &nbsp;Total Quantity (&mu;g)</p>
 +
<p>9)&nbsp; OD260/280</p>
 +
<p>10)&nbsp; OD260/230</p>
 +
<p>&nbsp;</p>
 +
<p><b><span style="font-size: medium">Please download and refer to the following documents for information on gDNA methods of preparation and delivery.</span></b></p>
 +
<p>1.<span style="color: #800000"><a href="/userfiles/Method of Sample(gDNA) Preparation for Sending out.doc">Method of Sample (gDNA) Preparation for Sending out</a></span></p>
 +
<p>2.<span style="color: #800000"><a href="/userfiles/Declaration_of_Shipment_for_anyone(2).doc">Declaration of Shipment</a><br />
 +
&nbsp;</span></p>
 
<p>&nbsp;</p>
 
<p>&nbsp;</p>
 
<h2>How it works</h2>
 
<h2>How it works</h2>
Line 88: Line 163:
 
<p><br />
 
<p><br />
 
&nbsp;&nbsp;&nbsp;&nbsp; <br />
 
&nbsp;&nbsp;&nbsp;&nbsp; <br />
&lt;Data Usage&gt; <br />
+
<span style="font-size: medium">Data Usage </span><br />
1. The genome data are provided by Genome Research Foundation. Anyone can use the data openfreely. <br />
+
1. The genome data&nbsp;is provided by Genome Research Foundation. Anyone can use the data freely.</p>
2. People who would like to acquire further information about the data for research publication and collaboration, please contact us. <br />
+
<p>2. People who would like to acquire further information about the data for research publication and collaboration, please contact us. <br />
Contact: <a href="mailto:info@kpgp.kr">info@kpgp.kr</a> / 82-31-888-9327<br />
+
Contact: <a href="mailto:info@pgi.re.kr">info@pgi.re.kr</a> / 82-43-235-8687</p>
&nbsp;</p>
+
<p>&nbsp;</p>

Latest revision as of 13:52, 27 October 2015

 

           Korean Personal Genome Project                                                                                                                                                                                           

Introduction

Korean Personal Genome Project (KPGP) is a research project by Genome Research Foundation (GRF). It is a part of PGP (The international Personal Genome Project (PGP).

Mission

  •  to function as Korean center for PGP (Harvard Medical School, George Church lab)
  •  to build a standard Korean genetic information database
  •  to activate the participative genome research
  •  to develop genome sequencing and analysis technologies in the age of personal genetic information services
  •  to establish an open community if sharing ethical, social, and legal issued in regard to genetic information

Research

  • Korean reference genome project
  • Rare diseases reference genome project
  • HLA alleles reference standard data production project

Participation 

Genetic Information Participation

It is a public participation. The human genetics education, screening and participant`s willingness determine an individual's participation. 

Research Participation

People who have research experiences in the field of human genetics, or who are willing to contribute to KPGP can participate through screening. 

Company Participation

Institutes and companies could participate. Sponsorship can greatly help KPGP`s activation.


Human genome researches have developed rapidly since the human genome project was completed in 2003. Recently large-scale production of human genome data is available with the advent of Next Generation Sequencing (NGS).

Genome Research Foundation (GRF), as a non-profit foundation, determines to open Korean genome data and the current available data of human genome sequence and analysis for free to allow researchers to study. Under the circumstances, OPEN KPGP started on 2011.

 

Genetic Data Usage Agreement for Research

 

1) Data Type

Every derived genetic information should be approved by relevant facility board.

1. Genetic information data- Individual's sequenced DNA and analyzed data.

2. Clinical information data- Clinical information does not include family tree, Phenotype and family medical history.

2) The Commission Process

1. Bioethics committee of Genome Research Foundation will make a decision through policy reviews and case consultation.

2. The Standards Commission

This commission should be controlled by Korea National Institute for Bioethics Policy.

Research, associate with potential social risks, eugenical problem and discrimination on the basis of genetic information when it comes to any aspects of physical looking, should be forbidden.

3. The Commission Process

Research project and IRB document, approved in each countries, will be required. If there is no provision for IRB approval, User must agree with additional consent documents that embodies the purpose of the data.

4. Evaluation (It will take at least one week)

3) Policy Agrement

Informed consent shall be documented by the use of a written consent form approved by the IRB, and signed by the subject or the subject's legally authourized representative.

And if necessary, the committee may request, require or otherwise obtain detailed investigation.

Data Release

Any additional costs to the subject that may result from participation in the research.

4) Data Source Agrement

The Genome Research Foundation should review and approve specifying the conditions under which data may be accepted, and ensuring adequate provisions to protect the privacy of subjects and maintain the confidentiality of data.

To cite the data source in any publications or research based upon these data, and to provide a copy of any publications, the following citation should be included in any research reports, papers, or publications based on these data:

Produced and distributed data should have references in Acknowledgement, Methods, Abstract.

How to download

After accessing to the OPEN KPGP website, select the desired data from DATA DOWNLOAD to download it through the Web and FTP.
Please understand that the downloading may be very slow due to Network load. (The speed of downloading 20 people’s data through KT cloud is stable, please use it as an alternative.)

 

Hard disk request

You can get data hard disks by requesting it to the administrator. However, the hard disk and processing costs will occur.
Cost:

  • Hard disks
  • Operating costs (labor and server equipment operating costs).
  • Shipping : door to door delivery(domestic only) / international shipping : please contact. (info@kpgp.kr 

(The data charges are variable based on the quantity and price of the hard disk, one hard disk can contain different numbers of samples.)

1) Raw sequencing data

Sample no. Cost(excluding V.A.T)
~10 115,000 (KRW) 
~20 170,000 (KRW)
~30 260,000 (KRW)
~40 340,000 (KRW)

 2) Data included : raw sequencing data, aligned data, genome variation, nonsynonymous SNVs

Sample no. Cost(excluding V.A.T)
~10 310,000 (KRW) 
~20 530,000 (KRW) 
~30 750,000 (KRW)
~40 880,000 (KRW)

 Date for pricing: 2011.09

Method of Sample (gDNA) Preparation for Sending out 

1. Sample(gDNA) Preparation

1)  DNA should be dissolved in TE buffer (Tris 10mM pH 8,0, 0.1 mM EDTA) or 10 mM Tris pH 8.0.

2)  Do Not Dissolve in Water

 

2. Sample(gDNA) Requirement

1)   Amount and concentration spec. : over 20 ug of gDNA with >50 ng/ul

 This amount is required for

a.  Whole genome sequencing (30X)

b.  Whole exome sequencing (50X)

c.  Genotyping

2)  Sample(gDNA) should be : OD260/280=1.8~2.0; free of protein, RNA, or other visible contamination

 

3. Sample(gDNA) Packing Information 

This way is only available when DNA is dissolved in TE or Tris buffer.

1)  If not, please pack DNA with icepack in icebox and use Fedex or DHL service

2)  Mark sample information on tube (concentration, sample name…what you want)

3)  Seal the cap of tube with parafilm well

4)  Wrap the tube with paper towel or equivalent

5)  Put into the 50 ml Falcon tube and close the cap

6)  Send the sample with air cushion envelop by FEDEX or DHL or equivalent

 

4. Requirement of Sample(gDNA) Information

1)  Sample type: DNA

2)  Condition: DNA in TE buffer or EB buffer or equivalent. Not in water

3)  Gel image of DNA electrophoresis

4)  Species

5)  No. of Tubes

6)  Concentration (ng/μl)

7)  Volume (μl)

8)  Total Quantity (μg)

9)  OD260/280

10)  OD260/230

 

Please download and refer to the following documents for information on gDNA methods of preparation and delivery.

1.Method of Sample (gDNA) Preparation for Sending out

2.Declaration of Shipment
 

 

How it works

 

 

 


    
Data Usage
1. The genome data is provided by Genome Research Foundation. Anyone can use the data freely.

2. People who would like to acquire further information about the data for research publication and collaboration, please contact us.
Contact: info@pgi.re.kr / 82-43-235-8687